Prot# GS-US-418-3898: Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Coliti

Project: Research project

Project Details

Effective start/end date7/19/177/19/20


  • PRA Health Sciences (GS-US-418-3898 // GS-US-418-3898)
  • Gilead Sciences, Inc (GS-US-418-3898 // GS-US-418-3898)